Sea Mild Biotechnology Co., Ltd. (7516.TWO)

TWD 10.3

(-1.44%)

EBITDA Summary of Sea Mild Biotechnology Co., Ltd.

  • Sea Mild Biotechnology Co., Ltd.'s latest annual EBITDA in 2023 was 19.31 Million TWD , up 506.15% from previous year.
  • Sea Mild Biotechnology Co., Ltd.'s latest quarterly EBITDA in 2024 Q1 was 4.77 Million TWD , up 116.59% from previous quarter.
  • Sea Mild Biotechnology Co., Ltd. reported an annual EBITDA of -5.63 Million TWD in 2022, up 128.58% from previous year.
  • Sea Mild Biotechnology Co., Ltd. reported an annual EBITDA of -20.32 Million TWD in 2021, up 28.92% from previous year.
  • Sea Mild Biotechnology Co., Ltd. reported a quarterly EBITDA of 4.77 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • Sea Mild Biotechnology Co., Ltd. reported a quarterly EBITDA of N/A for 2023 FY, up 506.15% from previous quarter.

Annual EBITDA Chart of Sea Mild Biotechnology Co., Ltd. (2023 - 2016)

Historical Annual EBITDA of Sea Mild Biotechnology Co., Ltd. (2023 - 2016)

Year EBITDA EBITDA Growth
2023 19.31 Million TWD 506.15%
2022 -5.63 Million TWD 128.58%
2021 -20.32 Million TWD 28.92%
2020 -25.24 Million TWD 80.86%
2019 -121.25 Million TWD -2255.57%
2018 -2.34 Million TWD 85.35%
2017 22.26 Million TWD 11.71%
2016 -26.34 Million TWD 0.0%

Peer EBITDA Comparison of Sea Mild Biotechnology Co., Ltd.

Name EBITDA EBITDA Difference
Dr. Wu Skincare Co., Ltd. 535.45 Million TWD 96.392%
Mikobeaute International Co., Ltd. 127.27 Million TWD 84.821%
Shiny Brands Group Co., Ltd. 536.02 Million TWD 96.396%
TCI Co., Ltd. 1.87 Billion TWD 98.967%
Fu Burg Industrial Co., Ltd. -16.62 Million TWD 216.178%
Grand Hall Enterprise Co., Ltd. 393.82 Million TWD 95.095%
Tittot Company Limited -18.92 Million TWD 202.082%